광학 분할에 의한 (S)-(+)-Pranidipine의 제조방법
Preparation of (S)-(+)-Pranidipine by Optical Resolution
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
본 연구에서는 칼슘채널 차단제로서 항고혈압 작용을 가진 (S)-(+)-pranidipine의 광학 분할에 의한 효과적인 제조방 법을 제시하였다. (±)-Pranidipine을 가수분해시켜 얻은 monocarboxylic acid 5의 라세미 혼합물에 광학 활성이 있는 quinidine 을 첨가하여 염을 형성한 다음 불용성 부분입체이성질체 염을 여과하고 염기와 산으로 처리하여 (R)-(-)-carboxylic acid 7을 분리하였고 이 carboxylic acid를 cinnamyl alcohol과의 에스터화 반응에 의해 (S)-(+)-pranidipine을 합성하였다. 이 화합물의 거 울상 초과량(enantiomeric excess, ee)을 카이랄 HPLC로 분석한 결과 100% ee 값이 얻어졌고, 합성 과정에서 강염기 사용과 무수 조건 및 초저온 조건을 배제하였는바 이는 산업상 매우 유용한 개량방법이라 하겠다.
Abstract
In this study, the effective preparation method of (S)-(+)-pranidipine, the active component of antihypertensive drug as a calcium channel blocker, was developed using optical resolution. The racemic monocarboxylic acid 5 obtained by the hydrolysis of (±)-pranidipine was mixed with optically active quinidine to form salts, and the insoluble diastereomeric salt was collected and successive treatment with base and acid furnished (R)-(-)-carboxylic acid 7. (S)-(+)-Pranidipine was prepared by esterification of this acid with cinnamyl alcohol, and the analysis by chiral HPLC showed 100% enantiomeric excess (ee). This process would be industrially very useful to prepare chiral (S)-(+)-pranidipine, since the use of strong base and anhydrous solvents, and ultra-low temperature condition were excluded in this process.
참고문헌 (15)
- Ioan, P., , Curr. Med. Chem, 18, pp.4901~ (2011)
- Nakayama, N., , Arzneimittelforschung-Drug Res, 43, pp.1266~ (1993)
- Mori, T., , Mol. Cell. Biochem, 178, pp.335~ (1998)
- Hirano, T., , Eur. J. Pharmacol, 324, pp.201~ (1997)
- Franckowiak, G., , Eur. J. Pharmacol, 114, pp.223~ (1985)
- Williams, J. S., , Biochem. Biophys. Res. Commun, 131, pp.13~ (1985)
- Gjorstrup, P., , Eur. J. Pharmacol, 122, pp.357~ (1986)
- Hirano, T., , Fundam. Clin. Pharmacol, 13, pp.650~ (1999)
- Fleckenstein, A., , Circul. Res, 52, pp.I3~ (1983)
- Ahuja, S., "Chiral Separation Methods for Pharmaceutical and Biotechnological Products" (2011), John Wiley & Sons
- Kadoiri, A., "Optically active 1,4-dihydropyridine derivatives and methods of producing the same, JP 6,043,397B", ~ (1994)
- Ikawa, H., "1,4-Dihydropyridine derivatives and methods of producing the same, U. S. Patent 5,763,614", ~ (1998)
- Kim, M.-S., "S-(+)-Pranidipine and methods of producing the same, KR Patent 10-0832659", ~ (2008)
- Still, W. C., , J. Org. Chem, 43, pp.2923~ (1978)
- Shibanuma, T., , Chem. Pharm. Bull, 28, pp.2809~ (1980)